The size of the North America Digital Breast Tomosynthesis Equipment Market was worth USD 409.37 million in 2022. This figure is forecasted to grow 805.65 Million by 2027, showcasing a CAGR of 14.5% from 2022 to 2027.
Y-O-Y growth in the incidence of breast cancer in North American countries is predicted to drive market growth. Breast cancer is the most common and regular kind of cancer among women, and nearly 2.1 million people have breast cancer yearly. Advancements in technology for enhancing new and inventive imaging products are stimulating the market. Every 1 in 8women, i.e., 13%, will be identified with breast cancer in their lifetime, and 1 in 39 women means 3% die of breast cancer in the US, in 2019, according to the American Cancer Society. The rising incidence rate of cancer in developing countries with a mounting lifespan and growing obtainment of unhealthy lifestyles escalates the market. Huge vital players are paying their attention to acquiring partnership and collaboration strategies to enlarge their product portfolio. Planmed Oy combined with Disior Oy for integrating Disior's orthopedic analysis software along with Planmed's high-tech cone-beam Computed Tomography (CBCT) scanner, Planned Verity in 2018 November.
Strict training requirements for radiologists and technologists, scarcity of reimbursement policies from government and private organizations hamper the region's DBT equipment growth. The increasing cost of the DBT treatment and the maintenance and installation of these devices restrict the market.
This research report on the North America Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories:
By End User:
In 2019, North America was the leading region in the global DBT equipment market. It will retain its position till 2022. The US accounted for the largest market share. Growing breast cancer across the world and a surge in tomosynthesis usage propel the growth in the market. Massive demand for innovative products, increasing screening acquisition, and experienced healthcare professionals are adding fuel to the region's market.
The United States DBT Equipment market is forecasted to account for the largest share in the North American market due to increasing awareness regarding the devices' usage, and a high determining rate is driving the market. Around 627,000 women lost their lives due to breast cancer, which is nearly 15% of women's cancer deaths.
Canada is witnessing rapid growth in the DBT equipment market because of the existence of highly enhanced infrastructure, and stimulating healthcare expenditure in the region is to accelerate the development of DBT in North America.
Promising Companies leading the North America Digital Breast Tomosynthesis (DBT) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l. and Planmed Oy.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com